跳至主要内容
临床试验/NCT04407936
NCT04407936已完成不适用

Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention

Guangdong Provincial People's Hospital1 个研究点 分布在 1 个国家目标入组 88,938 人开始时间: 2007年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
88,938
试验地点
1
主要终点
All-cause mortality

研究概览

简要总结

As a single center, retrospective observation study in Guangdong Institute of Cardiovascular Diseases, this study included the main study population of patients who underwent coronary angiography and / or coronary intervention from January 2007 to Decemeber 2018. The hospitalization information was collected in the form of direct derivation of the case, and cardiac and renal adverse events were collected through outpatient recorder system. All-cause death information was obtained from the Public Security and matched to the electronic Clinical Management System of the Guangdong Provincial People's Hospital records.

详细描述

This is a single center, retrospective observation study collecting data on 88938 coronary angiography and / or coronary intervention patients from January 2007 to Decemeber 2018. Data regarding demographic information, admission diagnoses and history of present illness, biomarkers and details on preventive hydration and medications will be collected. The primary endpoint of this study is All-cause mortality, and secondary endpoints are Adverse Cardiovascular and Kidney Events.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients referred to CAG or PCI;

排除标准

  • 未提供

结局指标

主要结局

All-cause mortality

时间窗: From hospital admission to 13 years follow-up

Admission Patients Died for all-cause mortality within 13 years.

次要结局

  • Contrast-Induced Acute Kidney Injury (CI-AKI 0.3)(48 hours)
  • Cystatin C based CI-AKI (CI-AKI cyc)(24-48 hours)
  • The change of eGFR, calculate based on CrCl and serum cystatin C(48-72 hours)
  • Contrast-induced Persistent kidney injury (CI-PKI)(3 months)
  • Incidence of major adverse cardiovascular events(3-12months)
  • Follow-up major adverse cardiovascular and clinical events(3-12months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jiyan Chen

Director

Guangdong Provincial People's Hospital

研究点 (1)

Loading locations...

相似试验